These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2037705)

  • 1. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of pinacidil in patients with and without indomethacin pretreatment.
    Cinquegrani MP; Liang CS
    Clin Exp Hypertens A; 1988; 10(3):411-31. PubMed ID: 3359658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an antihypertensive vasodilator, pinacidil, on regional blood flow in conscious spontaneously hypertensive rats.
    Kimura S; Fujioka S; Fukui K; Tamaki T; Iwao H; Abe Y
    J Pharmacobiodyn; 1988 Jun; 11(6):430-7. PubMed ID: 3171884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of pinacidil and propranolol alone and in combination in normal humans.
    Nicholls DP; McNeill J; Harron DW; Shanks RG
    J Cardiovasc Pharmacol; 1986; 8(1):51-4. PubMed ID: 2419692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute haemodynamic effects of pinacidil in man.
    Nicholls DP; Murtagh JG; Scott ME; Morton P; Shanks RG
    Br J Clin Pharmacol; 1986 Sep; 22(3):287-92. PubMed ID: 3768241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
    Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
    Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
    Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
    Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous pinacidil in the acute treatment of hypertension.
    Rijk MC; Thien T
    J Clin Pharmacol; 1987 Jul; 27(7):468-74. PubMed ID: 3308975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and myocardial blood flow. Profiles of pinacidil and nitroprusside in conscious dogs.
    Dubé GP; Greenfield JC
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):144-50. PubMed ID: 2021445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers.
    Thuillez C; Pussard E; Bellissant E; Richer C; Kechrid R; Giudicelli JF
    Br J Clin Pharmacol; 1991 Jan; 31(1):33-9. PubMed ID: 2015168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB; Pedersen EB
    Eur J Clin Pharmacol; 1993; 45(1):29-35. PubMed ID: 8405026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm.
    Simon AC; Levenson JA; Bouthier JD; Benetos A; Achimastos A; Fouchard M; Maarek BC; Safar ME
    Am J Cardiol; 1984 Mar; 53(6):781-5. PubMed ID: 6322565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension.
    Muiesan G; Fariello R; Muiesan ML; Christensen OE
    Eur J Clin Pharmacol; 1985; 28(5):495-9. PubMed ID: 3899669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
    Johnston GD; Finch MB; Shanks RG
    Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Clin Pharmacol Ther; 1980 Jun; 27(6):733-43. PubMed ID: 6991196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
    Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
    Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.